Sankil Pharmaceuticals Ltd, Lagos
Business Directory »
Medicine / Health
Sankil Pharmaceuticals Ltd. is a Joint-Venture company between Sankil Nigeria Ltd. and Shubham Pharmachem Pvt Ltd.
Sankil Nigeria Ltd. is a diversified manufacturing and trading business house of Nigeria with over 15 years. Sankil is managed by Jagdish Bhojwani and Pradeep Bhojwani. It has a strong power systems business under the brand 'Mopower', Its strength is in international trading operations and is most visible in Nigeria through its most famous brands viz., Golden Nuts, Golden Chips & Krisps, a range of ready to eat snacks, that it manufactures and markets.
Shubham Pharmachem Pvt Ltd. has over four decades of experience in Pharmaceutical API business. Shubham is involved in operations in India and in exports of API and Herbal products worldwide and exports of Chinese & European APIs. Shubham is managed by Rajesh, Manish & Ashish Jajodia, technocrats having vast experience in the field and it will bring its sourcing and product expertise to Sankil Pharmaceuticals.
The mandate for Sankil Pharmaceuticals is to be a "TOTAL PHARMA OUTSOURCING" company and cater to the demand of pharma raw material requirements in Nigeria. Today with sourcing from the best and most cost competitive manufacturers around the world and a deep knowledge of the Global API market that Shubham brings on board, and the network and resources of Sankil , Sankil Pharmaceuticals is poised to be a significant player in this industry.
Sankil has a NAFDAC approved warehouse with a 100 MT storage capacity and is supported by competent Pharmacists. Currently, Sankil is focusing on wide spectrum API’s like Antibiotics, Pain Management Drugs, Anti Malarial, Gastro and Excipients. Sankil has an expertise to provide any new molecule with technical support like DMF’s and stability data.
Sankil Pharma is a one stop resource for pharma companies and will provide APIs, formulations, finished products as per the requirements. Sankil aims to accelerate Nigeria's growth in pharma sector through faster to-market cycles for Pharma companies, and will add on more products as the market grows.